This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Yansheng Wu
Vice President, Global Head of CMC & Regulatory at Hongene Biotech Corporation, USA
Speaker

Profile

With over 20 years of experience in the global biotechnology and pharmaceutical industry, including Bayer, Archemix, Baxter/Baxalta, Shire, Alexion, Sperogenix Therapeutics and Hongene Biotech. Working experience on Analytical Development, GMP compliance, Product Quality, and CMC, from pre-clinical to commercial products. Hands on experience on oligonucleotide. Hold a Ph.D. in Organic Chemistry.

Agenda Sessions

  • Regulatory Strategy for Chemoenzymatic siRNA Manufacturing Process

    11:40am